Biomarker testing study for Friedreich’s ataxia
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at “biomarkers” (measurable signs in the body, like test results from blood or other checks) in people with Friedreich’s ataxia. It may help researchers understand the disease better and track changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic diagnosis of Friedreich’s ataxia, or you are a healthy person without a neuromuscular (movement/nerve) disorder
- You are between 6 and 70 years old
- You can safely do metabolic exercise testing
- If you take heart medicines, your dose and regimen have been stable for at least 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug given as a daily injection to see if it can improve walking and balance in people with Friedreich's ataxia.
This study uses heart tests (including ultrasound and MRI) to better understand how Friedreich’s ataxia affects the heart. You might benefit by getting detailed heart evaluation and contributing to research that could guide future care.
This study looks at two brain chemicals (GABA and glutathione) in children and teens aged 8–15 with Friedreich's ataxia, a rare genetic condition affecting movement and coordination. The research aims to understand how these chemicals change in the brain and may help guide future treatments.
This study uses an EEG (a painless test that records your brain's electrical activity) to map the brain connections in people with Friedreich's ataxia. It aims to better understand how the condition affects the brain.
This study looks at how the heart works during exercise and how that relates to fatigue in people with Friedreich's ataxia. You'll ride a stationary bike, and we'll measure your heart's output to understand fatigue better.
This study tests a new medicine called GV101 to see if it can help people with Friedreich's ataxia, a condition that affects movement and balance. The trial will check if GV101 is safe and if it improves symptoms.
Hear when a new Friedreich's Ataxia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.